Drusolv Therapeutics, Inc.
Mr. Edwards is a serial entrepreneur with 25 years of experience commercializing medical products, including the last 12 focused on age-related macular degeneration (AMD). Drusolv is his fifth startup, with successful exits for three of the previous four. He has raised $30M to support these ventures. Mr. Edwards has BS and MS degrees in physics from MIT and an MBA from University of Chicago.